These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11261824)

  • 1. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Higashiyama S; Monden M; Matsuura N
    Pathol Res Pract; 2001; 197(2):95-100. PubMed ID: 11261824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Fas and Fas ligand reflects the biological characteristics but not the status of apoptosis of intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Int J Mol Med; 2000 Nov; 6(5):581-6. PubMed ID: 11029528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Monden M; Matsuura N
    Liver; 2002 Apr; 22(2):145-9. PubMed ID: 12028409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
    Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Higashiyama S; Noda K; Miyoshi E; Monden M; Matsuura N
    Br J Cancer; 2001 May; 84(10):1377-83. PubMed ID: 11355950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma.
    Aishima S; Mano Y; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Jun; 44(6):1031-7. PubMed ID: 23260331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Oncology; 2001; 60(3):242-51. PubMed ID: 11340376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-aortic lymph node micrometastasis in patients with node-negative biliary cancer.
    Yonemori A; Kondo S; Matsuno Y; Ito T; Tanaka E; Hirano S
    Dig Surg; 2011; 28(4):315-21. PubMed ID: 21921633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ets-1 expression in extrahepatic bile duct carcinoma and cholangiocellular carcinoma.
    Ito Y; Miyoshi E; Takeda T; Sakon M; Tsujimoto M; Yokosaki Y; Monden M; Matsuura N
    Oncology; 2000 Apr; 58(3):248-52. PubMed ID: 10765128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Monden M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Oncology; 2000 Jun; 59(1):63-7. PubMed ID: 10895069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
    Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
    J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.